1. accesswire.com. (2022). https://www.accesswire.com/705856/9-Meters-Biopharma-Announces-Interim-Analysis-of-Phase-3-Study-of-Larazotide-for-Celiac-Disease-Does-Not-Support-Trial-Continuation.
2. Vaccine against autoimmune disease: Antigen-specific immunotherapy;Anderson;Current Opinion in Immunology,2013
3. Andrew, A., Passomore, R., & Urwin, H. (2022). Adults with coeliac disease are interested in therapeutics beyond the gluten free diet; a UK survey. In Proceedings of the ninteenth international celiac disease symposium, Sorrento, 169–170.
4. anokion.com. (2023). https://anokion.com/press_releases/anokion-announces-positive-data-from-phase-1-aced-clinical-trial-evaluating-kan-101-as-a-treatment-for-celiac-disease-presented-in-a-plenary-session-at-ddw-2022/.
5. The effect of infections on susceptibility to autoimmune and allergic diseases;Bach;New England Journal of Medicine,2002